跳到正文
原文
Nature 健康护理主题·· 2026-10-08AI 评分45

德国父母对基因组新生儿筛查的反应与偏好:基于场景的调查研究

Parental reactions to and preferences for genomic newborn screening in Germany: findings from a scenario-based survey experiment

AI 导读

该基于场景的调查研究探索了德国父母对假设基因组新生儿筛查结果的态度、偏好及主观风险感知。研究考察了不同临床行动性和外显率下的筛查结果如何影响父母获取信息的意愿,并分析了相关心理与社会因素。

正文

Introduction

Newborn screening (NBS) is a key element of secondary prevention in public health [1]. Traditionally, NBS has primarily used biochemical assays to detect conditions meeting specific criteria, such as early onset and availability of effective treatment. In Germany, 23 early-onset conditions (effective May 2026) are screened [2]. Advances in genome sequencing and decreasing costs have increased interest in incorporating genomic sequencing into NBS (genomic newborn screening, gNBS) to identify a broader spectrum of genetic disorders at birth and initiate treatment if available [3,4,5]. A central challenge is deciding which conditions to include [5, 6], especially late-onset, untreatable or uncertain conditions.

Parental preferences for gNBS have been explored through qualitative studies [7,8,9,10], questionnaires [11,12,13,14,15,16], vignette-based studies [17, 18], and discrete choice experiments (DCEs) [19, 20], consistently showing high general interest in gNBS. A DCE in Australia found broad public support for gNBS, with screening cost emerging as the most influential attribute [19]. Participants preferred programs with more diagnoses, but acceptance decreased for conditions with limited treatability and uncertain penetrance. In the NC NEXUS DCE on medically non-actionable conditions, penetrance and severity influenced parental choices, whereas the availability of quality-of-life interventions did not [20]. Higher education, health literacy, genetic testing experience, and future child planning increased gNBS interest in some studies [14, 17], while infant-health concerns or conservative views were associated with less support [17]. Gender differences were minor [20], and sociodemographic factors, including family history, showed inconsistent effects [14, 16]. Intentions to pursue gNBS were stronger when participants held positive beliefs about sequencing and completed a values clarification exercise [15].

Despite this evidence, several questions remain, particularly in the German context: how expecting parents would evaluate gNBS results differing in actionability and penetrance, which psychological and social factors could shape interest in such results, and how parents might perceive risk after result disclosure. Addressing these questions is important for ethically and socially responsive criteria for the potential implementation in Germany. This study was conducted within the project “NEW_LIVES” (https://www.klinikum.uni-heidelberg.de/en/new-lives-genomic-newborn-screening-programs), which aimed to develop ethical, legal, and social criteria for potential implementation of gNBS in Germany. In this study, we pursued three main aims. First, we examined parents’ general attitudes, preferences (e.g., regarding disclosure criteria and data storage), and emotional responses regarding hypothetical gNBS results, and explored preference profiles. Second, using hypothetical gNBS results that varied in actionability and penetrance, we investigated parents’ interest in receiving such results and examine both condition-related and individual predictors of interest. Actionability and penetrance were selected because previous research has linked limited actionability and lower or uncertain penetrance to parental ambivalence [7]. Third, we assessed parents’ subjective risk perception following hypothetical gNBS results, operationalized as diagnostic concern and subjective probability estimates, examined its correspondence with objective risk (condition penetrance), and identified predictors beyond objective risk.

Hypotheses and variable selection were guided by prior empirical evidence and Fuzzy Trace Theory (FTT) [21]. Previous evidence suggests that parents weigh perceived benefits and harms, consider whether testing aligns with their personal values and beliefs, and are influenced by emotional states and individual circumstances, such as family history, when deciding about genetic testing in children [22]. Thus, decisions are not based solely on cognitive evaluations of medical information, but also on emotional and social contexts. This perspective is consistent with FTT, which proposes that people often rely on the “gist” of information, particularly under uncertainty or heightened emotion [21]. Additionally, variable selection was informed by a prior focus group study in Germany [7], in which participants identified social expectations and trends as important influences on gNBS attitudes.

For interest in receiving gNBS findings, we distinguished condition-level characteristics from individual-level psychological and social factors. At the condition level, we hypothesized that interest in gNBS would be higher for conditions with greater actionability and higher penetrance [7]. At the individual level, we expected associations with diagnostic concern (worry about the disease occurring in the future) and perceived probability of disease onset. Consistent with FTT [21], we emphasized subjective risk perception because subjective interpretations of risk may be particularly relevant under uncertainty. We also expected interest to be associated with affective, experiential, social, and belief-related factors. Based on research on parental genetic testing decisions, we included attitudes and emotions toward gNBS, chronic condition experience, uncertainty tolerance, and anticipated coping with gNBS results as indicators of how individuals evaluate, respond to, and expect to manage genetic information [23]. We additionally included perceived social norms, as social expectations and trends were identified as potentially influential [7, 24]. Genetic determinism beliefs were included because viewing genes as strong determinants of health may increase the perceived relevance of genetic information. Accordingly, we expected higher interest with more positive attitudes and emotions toward gNBS, chronic condition experience, greater uncertainty tolerance, more positive anticipated coping, stronger perceived social norms, and stronger genetic determinism beliefs.

For study aim 3, we examined risk perception in more detail through perceived probability of disease onset and diagnostic concern. Previous studies linked higher perceived risk to family history [23, 25], distress, anxiety, depression, beliefs, and preventability or treatability [23, 26, 27]. While many studies assess risk perception before disclosure, less is known about risk perception after result disclosure. By assessing risk perception after hypothetical result disclosure, we examined responses to gNBS results differing in actionability and penetrance and whether subjective risk corresponded to objective risk, indicated by condition penetrance. We further explored associations with chronic condition experience, gNBS attitudes, actionability, emotions, stress, anxiety, and numeracy disease-onset uncertainty tolerance.

Materials and methods

Study design

We conducted a cross-sectional online survey (06-11/2024) on parental gNBS preferences and attitudes, using a single-choice-experiment design. Participants were exposed to randomized case scenarios and related questions, enabling between- and within-subject comparisons. They were masked for the randomization purposes and scenario variations. The study was approved by the ethics committee of Heidelberg Medical Faculty (S-215/2024) and pre-registered (https://doi.org/10.17605/OSF.IO/APZ6F).

Participants

Eligible participants were expecting parents and/or parents with at least one child under eight years, based on the NEW_LIVES consortium’s recommendation of a median age of disease-onset of seven years as a threshold for gNBS conditions in Germany [28, 29], making parents with (or expecting) children in this age range were considered particularly relevant. Participants had to be 18 years of age or older and proficient in German. Recruitment used flyers, email lists, parent cafés, forums, and patient organizations for families with chronic diseases. Compensation was 10 euros. The target sample size was 540, with ≥30 participants per group for stable estimates.

Procedure

Participants accessed the study online on SoSciSurvey, consented, and answered sociodemographic questions. After information on the current NBS and potential gNBS in Germany, they completed comprehension checks. They rated their agreement with statements reflecting potential advantages/hopes and disadvantages/worries of gNBS, emotions related to gNBS, and criteria for target diseases. Questionnaire-based randomization without replacement assigned each participant to two distinct scenarios from nine, describing gNBS results with varying actionability and genetic penetrance. After each scenario, participants rated emotions, interest in findings, risk perception, and anticipated coping. Additional variables followed. The survey included novel items and validated instruments; Appendix 1 contains the full questionnaire.

Measures

Building on a systematic review [22], we selected variables that were (a) consistently associated with testing behavior or interest, (b) particularly relevant for population-wide NBS (as opposed to diagnostic testing), and (c) measurable through self-report surveys.

  1. 1)

    Sociodemographics: Age, gender, highest level of education and experience with chronic disease in the close environment.

  2. 2)

    Attitudes toward gNBS: Agreement with potential hopes/benefits and concerns/worries regarding gNBS (5-point Likert scale + “don’t know” response option). Items partly adapted from prior gNBS [15] and preimplantation genetic diagnosis (PGD) studies [30], and developed within the NEW_LIVES consortium.

  3. 3)

    Emotions toward gNBS: Presence and strength of emotions (0-100 slider), selected based on focus group findings [7] and PGD research [30].

  4. 4)

    General gNBS preferences: Age of onset (categorices), penetrance (0-100% slider, for actionable/monitorable/non-actionable conditions), actionability and severity (0-100 sliders), and family-related information (categories). Items developed through discussions (NEW_LIVES consortium) and focus groups [7].

  5. 5)

    Case-scenarios: Interest in gNBS, anticipated coping with gNBS results, diagnostic concern (worry about disease manifestation), perceived probability of disease-onset, emotions associated with hypothetical gNBS finding (0-100 sliders). Scenarios varied by actionability (1: no specific treatment, but supportive therapies may help manage symptoms; 2: no effective treatment preventing symptoms and ensuring normal development, but options available that alleviate symptoms and improve quality of life; 3: effective treatment preventing severe symptoms and enabling normal development), and penetrance (1 = 25–49%, 2 = 50-74%, 3 = 75-100%).

  6. 6)

    Additional measures: Perceived social norms (3 items, adapted from Link et al. [31] and Paquin et al. [32]), “Tolerance for Ambiguity Scale” [33], item based on the English “Health Literacy” scale [24], anxiety (GAD-2 scale, short form of GAD-7) [34], perceived stress (PSS4-German) [35], numeracy [36], genetic determinism item (adapted from BabySeq Project [37]).

Data analysis

For aim 1 (exploring gNBS-related attitudes, emotions, and preferences towards gNBS), general, non-scenario-specific variables were analyzed descriptively. Reliability coefficients assessed internal consistency for newly developed item sets. Responses to positive/negative attitudes and emotion items were aggregated as means and compared with paired-sample t-tests. Group differences in attitude ratings by chronic condition experience and gender were examined using independent-samples t-tests or Wilcoxon rank-sum tests, depending on distributional assumptions. A latent profile analysis (LPA) of actionability, penetrance, and severity preferences identified profiles; post hoc tests compared participant characteristics.

For aims 2 and 3—examining interest in and risk perception of abnormal gNBS findings and their predictors—responses to the hypothetical scenarios were analyzed using multilevel models (MLMs; lme4 package [38]), accounting for the nesting of scenarios within participants. Interest in hypothetical gNBS results was modeled as an outcome for aim 2; for aim 3, perceived probability of disease onset and diagnostic concern were modeled separately to identify predictors of subjective risk perception. Full maximum likelihood estimation was applied. Predictors were centered before analysis (level 1: person mean; level 2: grand mean) [39]. Model assumptions were checked using residual plots and the DHARMa package [40]. Due to heteroscedasticity, outcomes were transformed (interest: reflection and Box-Cox transformation; perceived probability and diagnostic concern: logit transformation), and robust standard errors were computed (clubSandwich package [41]). Sensitivity analyses excluded influential outliers to ensure robustness. Sociodemographic variables not mentioned in the literature were included if marginally significant in bivariate analyses with the outcome variable.

Significance level was set at α = 0.05. P values were adjusted for multiple testing using Benjamini-Hochberg correction.

Results

Sample

Of 797 survey starters, 13 stopped at the study information, two lacked sufficient language proficiency, and six failed the inclusion criteria (pregnant (partner) and/or child <8 years). 216 participants did not complete the case-scenario section. The final sample included 556 participants (60.18% female), with a mean age of 34.8 (SD = 6.5) years. Table 1 shows additional characteristics.

Table 1 Sample description.

Full size table

Descriptives

Attitudes towards gNBS

Table 2 describes participants’ agreement with each attitude item.

Table 2 Agreement proportions, mean agreement, and standard deviations for the single attitude items.

Full size table

Cronbach’s alpha was α = 0.88 for the positive attitudes (perceived benefits/hopes) and α = 0.86 for the negative attitudes (perceived worries/concerns), indicating good internal consistency, supporting composite scores. Agreement with positive attitudes (M = 4.12, SD = 0.74) was significantly higher than with negative attitudes (M = 2.58, SD = 0.92), t (555) = 25.14, p < 0.001, Cohen’s d = 1.07 (large effect), suggesting an overall positive evaluation of gNBS among the participants. Chronic condition experience in the close environment was not associated with aggregated positive or negative attitudes. However, item-level comparisons indicated that individuals with chronic conditions experience more strongly endorsed gNBS as improving medical understanding (item positive attitude 02; Wilcoxon rank-sum test: W = 31395, r = −0.13, p < 0.05) and reported greater concerns about discrimination (item negative attitude 02; t(545) = − 3.86, d = −0.33, p < 0.01). No gender differences were found for attitude items, except for women being slightly more concerned about waiting for results, t(541) = − 2.97, p < 0.10.

Emotions towards gNBS

Figure 1 shows emotion ratings regarding hypothetical gNBS in participants’ own children. Cronbach’s alpha was α = 0.85 for positive and α = 0.78 for negative emotions, justifying composite scores. Positive emotions (M = 49.87, SD = 24.29) were rated higher than negative emotions (M = 41.67, SD = 20.64) regarding gNBS, t(555) = 5.31, p < 0.001, Cohen's d = 0.22 (small effect), further indicating an overall positive evaluation of gNBS among the participants.

Fig. 1: Mean agreement with emotions toward gNBS in one's own child.

A list of emotions was presented, and participants were asked to rate their emotions (presence and intensity) associated with the idea of gNBS in their child. Emotions were rated on a scale from 0 to 100. Selection of emotions was based on a previous study on preimplantation genetic diagnostics [30], a focus group study in Germany [7] and discussion in the NEW_LIVES group.

General preferences

Table 3 shows descriptives for all general preference items. Overall, parents were interested in gNBS information and accepted low thresholds for actionability, severity, and penetrance. Moreover, interest was high for information about conditions relevant to the child’s lifetime. A few participants preferred not to receive child or family-related information. Nevertheless, preferences varied across participants. To explore whether parents could be grouped according to similar preference patterns, an LPA was conducted. The LPA supported two profiles: open seekers (n = 202) and more cautious information seekers (n = 346; detailed in Appendix 2).

Table 3 Descriptives for general preference items.

Full size table

Scenario-specific findings

Interest in gNBS finding

Across scenarios, mean interest in findings (0–100 scale) was M = 78.8 (Md = 97.0, SD = 29.7), increasing with actionability (M = 73.03 for low actionability to M = 85.65 for high actionability) and penetrance (M = 76.00 for low penetrance to M = 80.99 for high penetrance). The intraclass correlation coefficient (ICC) of the null model was 0.67, meaning 67% of the variance was attributable to differences between individuals, supporting the use of an MLM addressing aim 2. Analyses included 1100 observations from 550 individuals. The random-intercept full model showed better fit than the random-intercept null model, χ²(14) = 360.02, p < 0.001, ΔAIC = 332), suggesting that predictors explained variance in interest beyond individual differences between participants.

Table 4 presents the MLM results. In summary, higher interest was associated with high actionability (no significant difference between low and moderate actionability) and moderate penetrance (50–74%). High penetrance (75–100%) became significant only when perceived probability was excluded from the model. As hypothesized, higher interest was also associated with chronic condition experience, higher anticipated coping ability, higher perceived probability, and more positive than negative attitudes. Contrary to expectations, no associations were found for uncertainty tolerance, genetic determinism views, perceived social norms influence, diagnostic concern, or emotions towards gNBS.

Table 4 Results from multilevel models for variables of interest, perceived probability and diagnostic concern.

Full size table

As the multilevel model did not show a significant effect for high versus low penetrance, exploratory post hoc contrasts (emmeans package [42]) were conducted to further examine pairwise differences between penetrance levels in a model excluding perceived probability. There were significant differences between low and moderate penetrance levels (Δ = 0.24, 95% CI [0.10, 0.39], p < 0.001) and between low and high penetrance levels (Δ = 0.28, 95% CI [0.13, 0.44], p < 0.001), but not between moderate and high penetrance levels (Δ = 0.04, 95% CI [−0.11, 0.19], p = 0.820), suggesting that, for interest in gNBS results, the distinction between penetrance below versus above 50% may be particularly relevant.

To compare the predictive value of objective and subjective risk, we exploratorily contrasted models with penetrance only vs. with perceived probability only. The perceived-probability-only model showed a better fit (ΔAIC = 5.43), suggesting it is a better predictor of interest, although both performed worse than the full model (penetrance-only: χ²=9.60, p < 0.01, ΔAIC = 7.6; probability-only: χ²(2) = 6.17, p < 0.05, ΔAIC = 2.1). Nevertheless, marginal R² was similar across models (R² = 0.33–0.34), indicating that the overall variance explained differed only minimally.

Exploratory adding gender, perceived stress, and anxiety yielded no significant fixed effects or model fit improvement, suggesting that these factors did not explain additional variance in interest beyond the main predictors.

Actionability vs. risk

To assess the relative contribution of different scenario-condition characteristics to parents’ interest, we conducted model comparisons in which actionability, penetrance, and risk-related predictors were removed from the model. Removing actionability reduced model fit more than removing penetrance (actionability: ΔAIC = 50.4, χ²(2) = 54.41, p < 0.001, marginal R² = 0.31; penetrance: ΔAIC = 2.1, χ²(2) = 6.17, p < 0.05, marginal R² = 0.33), or removing both penetrance and perceived probability (ΔAIC = 25.1, χ²(3) = 31.12, p < 0.001, marginal R² = 0.33). This suggests that actionability was a stronger determinant of model performance than penetrance or perceived probability, indicating that parents’ evaluations were more strongly shaped by whether a condition was perceived as actionable than by risk-related information.

Subjective risk perception

To explore subjective risk perception (aim 3), we compared the objective risk information provided in the scenarios (penetrance) with participants’ subjective risk estimates, indicated by perceived probability of disease onset. Both measures were strongly correlated, r = 0.57, p < 0.001, suggesting that participants’ risk estimates generally reflected the risk level provided in the scenario. As Fig. 2 shows, perceived probability increased with penetrance. For medium and high penetrance levels, participants’ estimates were close to the middle of the indicated risk range, whereas low-penetrance conditions tended to be estimated toward the upper end of the range. Diagnostic concern and penetrance showed a significantly small-to-moderate positive correlation (ρ = 0.25, p < 0.001). Diagnostic concern also varied by penetrance and was already elevated for low-penetrance results, suggesting that even comparatively uncertain findings may elicit concern. Exploratory post hoc contrasts showed that diagnostic concern was significantly higher for moderate and high compared with low penetrance, but did not differ significantly between moderate and high penetrance.

Fig. 2: Subjective risk measures per penetrance levels.

Penetrance levels include 25–49% risk of disease-onset (level 1), 50–74% risk of disease-onset (level 2), and 75–100% risk of disease-onset (level 3). Perceived probability of disease onset was measured on a scale from 0 (very unlikely) to 100 (very probable). Diagnostic concern reflects worry about the disease onset and was measured on a scale from 0 (not at all) to 100 (very concerned).

Perceived probability

The null model ICC was 0.37, so 37% of the variance reflected differences between individuals, supporting the use of an MLM. Analyses included 1098 observations from 549 participants. The random-intercept full model showed better fit than the random-intercept null model, χ²(18) = 369.55, p < 0.001, ΔAIC = 333.6), indicating that the predictors add explanatory value. Summarizing the findings from Table 4, higher perceived probability was predicted by higher penetrance, higher numeracy, and lower anticipated coping. More positive attitudes had a marginal effect. No significant effects emerged for negative attitudes, chronic illness experience, stress, anxiety, education, or gender. In sensitivity analyses excluding outliers/influential cases, more negative attitudes were positively associated with perceived probability, and actionability showed a marginal positive effect. An interaction model (penetrance × numeracy) yielded no significant numeracy main or interaction effects.

Diagnostic concern

The null model ICC was 0.40, suggesting that 40% of the variance was attributable to differences between individuals, supporting the use of an MLM. The model included 1098 observations from 549 participants. The random-intercept full model showed better fit than the random-intercept null model, χ²(18) = 220.74, p < 0.001, ΔAIC = 186.7). Accordingly, the predictors contribute to explaining variance in diagnostic concern. In summary, the results presented in Table 4 show that greater diagnostic concern was predicted by higher penetrance, female gender, more positive attitudes towards gNBS, less positive and more negative emotions towards the result, less anticipated coping, higher numeracy, and marginally higher anxiety. No significant effects emerged for actionability, education, negative attitudes, or stress.

Discussion

This online survey examined German parents’ general attitudes, emotions and preferences toward gNBS. Using hypothetical case scenarios, we further approximated disclosure preferences by assessing parents’ interest in these findings, and explored subjective risk perception. Overall, parents evaluated gNBS positively, expressing strong information demand.

Benefits outweigh concerns

Participants endorsed perceived benefits of gNBS more strongly than its potential concerns, indicating generally favourable attitudes towards gNBS. This is consistent with prior research reporting predominantly positive parental attitudes toward gNBS [14, 15]. Agreement was highest for early support and help-seeking benefits.” Participants’ main concern was waiting for results. As previous research found no link between this concern and behavioral intention [15], it may be best addressed through program design and communication, rather than interpreted as general opposition to gNBS. As with attitudes, positive emotions toward potential gNBS for one’s child were stronger than negative emotions, although ambivalence was strongest (see Fig. 1), highlighting the need for information materials and counseling to reduce ambivalence.

Compared with a German population-based survey [43], participants more strongly endorsed potential benefits (M = 4.13, SD = 0.78 vs. M = 3.82, SD = 0.89), t(1027) = 7.92, p < 0.001, d = 0.36) and less strongly endorsed potential disadvantages (M = 2.60, SD = 1.07 vs. M = 3.26, SD = 1.08), t(937) = − 12.61, p < .001, d = −0.61). However, this comparison should be interpreted cautiously because item wording and study context differed.

High interest in information

Participants showed high interest in genetic information across scenarios with varying actionability and penetrance. Participants further accepted relatively low thresholds for actionability, severity, and penetrance, indicating little preference for restricting disclosure. Only 11% endorsed the item, stating they would not want to receive gNBS information after their child’s birth (Table 3). This aligns with a large body of previous research reporting substantial interest in expanded screening results [44] and an estimated gNBS uptake of 87% in Australia [19], although general preferences varied considerably [44].

As detailed in Appendix 2, two preference profiles emerged based on participants’ minimum-threshold ratings for severity, actionability and penetrance, one highly open group and one more selective, yet still information-seeking, group. This variability might suggest that flexible gNBS programs may be needed to accommodate differing disclosure preferences. reportable findings. However, potential bias regarding result disclosure preferences due to social desirability, as well as other reasons for/against allowing parents to choose between different results categories to be disclosed, must be considered.

Actionability was associated with parents’ interest in the scenarios: although interest remained high at low actionability, it was greater for findings enabling effective treatment and normal development than for those offering only symptom relief. This aligns with evidence that parents weigh diagnostic benefits against limited treatment utility [19]. Model comparisons revealed that actionability was a stronger predictor than penetrance. GNBS frameworks have prioritized these criteria differently [6]. Actionability may have been a stronger predictor in our study because it might have been easier to understand than penetrance, which was presented only numerically and verbally rather than graphically [45]. and is generally difficult to communicate [46].

Interest remained high at low penetrance, but significantly higher when penetrance was >50%. When penetrance and interest were considered separately, both moderate and high penetrance were associated with higher interest than low penetrance, but did not differ from each other. This suggests that parents distinguished primarily between probabilities below and above approximately 50%, rather than responding proportionally to further increases in penetrance and aligns with the tendency to interpret genetic risk categorically (e.g., “low vs. high”) [26, 47]. Once the probability of disease exceeds a certain threshold, parents may therefore perceive a finding as sufficiently relevant to warrant interest despite remaining uncertainty.

However, when subjective risk perception was included in the full model, high penetrance (> 75%) was no longer a significant predictor. This indicates that perceived probability may be a more proximal predictor of interest than objective risk, highlighting the importance of addressing how parents interpret penetrance information in gNBS communication. Future studies should examine how different penetrance levels are perceived and translated into subjective risk, and how these perceptions influence parents’ interest in receiving results and illness perceptions regarding the child. Consistent with our findings, a nonlinear relation between perceived risk and interest in genetic testing was reported previously [48].

As hypothesized, a stronger predominance of positive over negative attitudes predicted higher interest, consistent with prior research [22]. Surprisingly, diagnostic concern (worry about disease onset) was not a significant predictor of interest in findings, possibly due to a ceiling effect.

Chronic condition experience also predicted interest, although evidence is mixed [14, 16, 19]. In our study, participants with and without such experience were equally represented, but recruitment through patient organizations and ongoing debates about gNBS in Germany may have influenced this association, limiting generalizability.

Anticipated coping ability predicted interest. Although rarely examined in gNBS preference research, it may help explain why some parents seek information while others hesitate despite recognizing benefits.

Several constructs were non-significant predictors. Uncertainty tolerance showed no effect, despite its conceptual relevance in genetic testing [49, 50], possibly because different forms of uncertainty were conflated. Genetic determinism views and perceived social norms were also nonsignificant, potentially reflecting the novelty of gNBS. Emotions towards gNBS were significant only when attitudes were excluded, suggesting overlap, but may matter more in real-life decisions than hypothetical scenarios.

Variability in risk perception measures and predictors

Perceived probability predicted interest in gNBS better than objective risks, but generally corresponded with it, despite some over- and underestimation. Mean perceived probability was near the upper risk level for low penetrance (25–40%) and mid-range for higher penetrance ( > 50%). Diagnostic concern exceeded objective risk across all penetrance levels, possibly reflecting social desirability; similarly, previous research found disproportionately elevated anticipated worry at 50% risk [48]. Hopes and benefits towards gNBS predicted perceived probability and diagnostic concern. Female gender predicted only diagnostic concern. Numeracy had a nuanced role: higher numeracy was associated with higher perceived probability for penetrance above 50% and greater diagnostic concern for low penetrance ( < 50%). These findings reinforce the multidimensional nature of risk perception [51]. Unlike other studies, actionability did not predict risk perception, warranting research on how treatability and probability jointly shape perceived meaning and concern [26].

Limitations and strengths

The sample’s high education level may limit generalizability, especially given evidence that socioeconomic indicators relate to attitudes [43]. The use of hypothetical scenarios was ethically appropriate as gNBS is not implemented in Germany, but doesn’t equal real-world decision-making. More risk increments might have supported finer-grained analysis of risk perception, but complexity and sample-size constraints required simplification. Although parity may influence parents’ interest in gNBS [14], we were unable to examine these factors reliably because the item assessing the number of children appeared to be interpreted inconsistently despite the instruction to count the current pregnancy as one child; future studies should assess parity and pregnancy status more explicitly.

Strengths include a relative balance regarding gender and experience with chronic disease in the close environment. The study also incorporated a form of values clarification via engagement with benefit/concern items. Finally, the focus on subjective factors (emotions, perceived risk, coping) provides a more comprehensive picture of how parents evaluate gNBS findings. This study provides the first survey data specifically focusing on German parents’ gNBS preferences, using a comprehensive dataset and scenario-based assessment.

Implications

Because our scenarios captured interest and emotional reactions to hypothetical results concurrently, findings likely reflect evaluative appraisals more than prospective real-world decisions. Future research should therefore examine factors that drive actual uptake of gNBS and compare hypothetical interest with real-world decisions. Longitudinal studies in implementation contexts could follow parents across the screening process, from before information sessions through information provision, decision-making, disclosure, and follow-up, to examine how constructs such as anticipated and actual coping, risk perception, emotional responses, and interest in results develop over time.

The relevance of attitudes, risk perception, and coping ability suggests the importance of supporting parents in shaping their attitudes and in further investigating how these are formed. Highly anticipated diagnostic concerns elicited for low-penetrance risks may warrant a cautious approach to returning such findings. Decision aids could help navigate complexity and high information needs by clarifying benefits, risks, and coping resources, especially in the context of population-based screening programs, requiring structured, accessible communication at scale. Genetic counseling could complement such materials as an additional source of support in selected cases, particularly for parents with persistent ambivalence or unresolved questions and may be particularly important after disclosure of abnormal gNBS results.

Conclusion

Our design captured evaluative reactions to a hypothetical result based on case scenarios and assessed interest concurrently. We identified relevant associations that likely reflect how parents evaluate the value of gNBS results in light of their cognitive and emotional responses. These insights can guide condition selection and parents' support in the future implementation of gNBS.

Data availability

Data and materials are available upon request.

Code availability

Code is available upon request.

References

  1. Mütze U, Kölker S. Evaluierung und Optimierung des Neugeborenenscreenings mittels strukturierter Langzeitbeobachtung – am Beispiel der angeborenen Stoffwechselerkrankungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023;66:1249–58. https://doi.org/10.1007/s00103-023-03772-7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Federal Joint Committee Germany (Gemeinsamer Bundesausschuss). Früherkennung: G-BA erweitert Neugeborenen-Screening auf Vitamin-B12-Mangel und weitere Stoffwechselerkrankungen 2025. https://www.g-ba.de/presse/pressemitteilungen-meldungen/1257/ 2025.

  3. Brennenstuhl H, Schaaf CP. Genomic newborn screening: research approaches, challenges, and opportunities. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023;66:1232–42. https://doi.org/10.1007/s00103-023-03777-2.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wojcik MH, Gold NB. Implications of genomic newborn screening for infant mortality. Int J Neonatal Screen. 2023;9:12 https://doi.org/10.3390/ijns9010012.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dikow N, Ditzen B, Kölker S, Hoffmann GF, Schaaf CP. From newborn screening to genomic medicine: challenges and suggestions on how to incorporate genomic newborn screening in public health programs. Medizinische Genetik. 2022;34:13–20. https://doi.org/10.1515/medgen-2022-2113.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Schnabel-Besson E, Mütze U, Dikow N, Hörster F, Morath MA, Alex K, et al. Wilson and Jungner revisited: are screening criteria fit for the 21st century? Int J Neonatal Screen. 2024;10:62 https://doi.org/10.3390/ijns10030062.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Doll ES, Mahal J, Alex K, Lerch SP, Kölker S, Schaaf CP, et al. Tension between the need for certainty and numerous uncertainties—a focus group study on various perspectives on a potential genomic newborn screening program in Germany. J Genet Couns. 2025;34:1–16. https://doi.org/10.1002/jgc4.70004.

    Article  Google Scholar 

  8. Ulph F, Dharni N, Bennett R, Lavender T. Consent for newborn screening: screening professionals’ and parents’ views. Public Health. 2020;178:151–8. https://doi.org/10.1016/j.puhe.2019.08.009.

    Article  PubMed  Google Scholar 

  9. Cao M, Notini L, Ayres S, Vears DF. Australian healthcare professionals’ perspectives on the ethical and practical issues associated with genomic newborn screening. J Genet Counseling. 2023;32:376–86. https://doi.org/10.1002/jgc4.1645.

    Article  Google Scholar 

  10. Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. Parental views on expanded newborn screening using whole-genome sequencing. PEDIATRICS. 2016;137:S36–46. https://doi.org/10.1542/peds.2015-3731H.

    Article  PubMed  PubMed Central  Google Scholar 

  11. DeLuca JM. Public attitudes toward expanded newborn screening. J Pediatr Nurs. 2018;38:19–23. https://doi.org/10.1016/j.pedn.2017.10.002.

    Article  Google Scholar 

  12. Etchegary H, Dicks E, Green J, Hodgkinson K, Pullman D, Parfrey P. Interest in newborn genetic testing: a survey of prospective parents and the general public. Genet Test Mol Biomark. 2012;16:353–8. https://doi.org/10.1089/gtmb.2011.0221.

    Article  Google Scholar 

  13. Etchegary H, Dicks E, Hodgkinson K, Pullman D, Green J, Parfey P. Public attitudes about genetic testing in the newborn period. J Obstet Gynecol Neonatal Nurs. 2012;41:191–200. https://doi.org/10.1111/j.1552-6909.2012.01341.x.

    Article  PubMed  Google Scholar 

  14. Prosenc B, Cizek Sajko M, Kavsek G, Herzog M, Peterlin B. Perception of genomic newborn screening among peripartum mothers. Eur J Hum Genet. 2024;32:163–70. https://doi.org/10.1038/s41431-023-01497-4.

    Article  PubMed  Google Scholar 

  15. Paquin RS, Peinado S, Lewis MA, Biesecker BB, Rini C, Roche M, et al. A behavior-theoretic evaluation of values clarification on parental beliefs and intentions toward genomic sequencing for newborns. Soc Sci Med. 2021;271:112037. https://doi.org/10.1016/j.socscimed.2018.11.017.

    Article  PubMed  Google Scholar 

  16. Waisbren SE, Bäck DK, Liu C, Kalia SS, Ringer SA, Holm IA, et al. Parents are interested in newborn genomic testing during the early postpartum period. Genet Med. 2015;17:501–4. https://doi.org/10.1038/gim.2014.139.

    Article  PubMed  Google Scholar 

  17. Goldenberg AJ, Dodson DS, Davis MM, Tarini BA. Parents’ interest in whole-genome sequencing of newborns. Genet Med. 2014;16:78–84. https://doi.org/10.1038/gim.2013.76.

    Article  PubMed  Google Scholar 

  18. Tarini BA, Singer D, Clark SJ, Davis MM. Parents’ interest in predictive genetic testing for their children when a disease has no treatment. Pediatrics. 2009;124:e432–438. https://doi.org/10.1542/peds.2008-2389.

    Article  PubMed  Google Scholar 

  19. Peters R, Best S, Lynch F, Vears DF, Downie L, Archibald AD, et al. Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia. Am J Hum Genet. 2025;112:1515–27. https://doi.org/10.1016/j.ajhg.2025.05.001.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lewis MA, Paquin RS, Roche MI, Furberg RD, Rini C, Berg JS, et al. Supporting parental decisions about genomic sequencing for newborn screening: the NC NEXUS decision aid. Pediatrics. 2016;137:S16–23. https://doi.org/10.1542/peds.2015-3731E.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Reyna VF. A theory of medical decision making and health: fuzzy trace theory. Med Decis Mak. 2008;28:850–65. https://doi.org/10.1177/0272989X08327066.

    Article  Google Scholar 

  22. Doll ES, Lerch SP, Schmalenberger KM, Alex K, Kölker S, Brennenstuhl H, et al. How do parents decide on genetic testing in pediatrics? A systematic review. Genet Med. 2025;27:101390. https://doi.org/10.1016/j.gim.2025.101390.

    Article  PubMed  Google Scholar 

  23. Tilburt JC, James KM, Sinicrope PS, Eton DT, Costello BA, Carey J, et al. Factors influencing cancer risk perception in high-risk populations: a systematic review. Hereditary Cancer Clin Pract. 2011;9:2. https://doi.org/10.1186/1897-4287-9-2.

    Article  Google Scholar 

  24. Morris NS, MacLean CD, Chew LD, Littenberg B. The single item literacy screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pr. 2006;7:21 https://doi.org/10.1186/1471-2296-7-21.

    Article  Google Scholar 

  25. Airikkala E, Laaksonen M, Halkoaho A, Kaunonen M. Perception of inherited risk in type 2 diabetes: a systematic review. Front Public Health 2023;11. https://doi.org/10.3389/fpubh.2023.1293874.

  26. Wöhlke S, Schaper M, Schicktanz S. How uncertainty influences lay people’s attitudes and risk perceptions concerning predictive genetic testing and risk communication. Front Genet 2019;10. https://doi.org/10.3389/fgene.2019.00380.

  27. Cicero G, De Luca R, Dorangricchia P, Lo Coco G, Guarnaccia C, Fanale D, et al. Risk perception and psychological distress in genetic counselling for hereditary breast and/or ovarian cancer. J Genet Counseling. 2017;26:999–1007. https://doi.org/10.1007/s10897-017-0072-0.

    Article  Google Scholar 

  28. Alex K, Doll ES, Straub H, Schnabel-Besson E, Dikow N, Neth L, et al. Empfehlungen zu ethischen, rechtlichen, sozialen und medizinischen Rahmenbedingungen für ein genomisches Neugeborenenscreening-Programm in Deutschland. Forum Marsilius-Kolleg 2025;Bd. 26:sozialen und medizinischen Rahmenbedingungen für ein genomisches Neugeborenenscreening-Programm in Deutschland. https://doi.org/10.11588/FMK.2025.26.111791.

  29. Schnabel-Besson E, Dikow N, Alex K, Mütze U, Straub H, Doll ES, et al. A multi-dimensional framework for establishing and managing a genomic newborn screening program 2025. https://doi.org/10.1101/2025.06.17.25329471.

  30. Finck C, Meister U, Stöbel-Richter Y, Borkenhagen A, Brähler E. Ambivalent attitudes towards pre-implantation genetic diagnosis in Germany. Eur J Obstet Gynecol Reprod Biol. 2006;126:217–25. https://doi.org/10.1016/j.ejogrb.2005.11.031.

    Article  PubMed  Google Scholar 

  31. Link E, Baumann E, Schrimpff C, Fisse T, Klimmt C. What drives or inhibits individuals’ intention to seek information about medical innovations? Findings from an online survey among german residents. Sci Commun. 2024;46:725–57. https://doi.org/10.1177/10755470241253815.

    Article  Google Scholar 

  32. Paquin RS, Peay HL, Gehtland LM, Lewis MA, Bailey DB. Parental intentions to enroll children in a voluntary expanded newborn screening program. Soc Sci Med. 2016;166:17–24. https://doi.org/10.1016/j.socscimed.2016.07.036.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Dalbert C. Die Ungewissheitstoleranzskala: Skaleneigenschaften und Validierungsbefunde 1999;Hallesche Berichte zur Pädagogischen Psychologie Nr. 1.

  34. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092 https://doi.org/10.1001/archinte.166.10.1092.

    Article  PubMed  Google Scholar 

  35. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385. https://doi.org/10.2307/2136404.

    Article  PubMed  Google Scholar 

  36. Silverstein MC, Bjälkebring P, Shoots-Reinhard B, Peters E. The numeric understanding measures: developing and validating adaptive and nonadaptive numeracy scales. Judgm Decis Mak. 2023;18:e19. https://doi.org/10.1017/jdm.2023.17.

    Article  Google Scholar 

  37. Pereira S, Smith HS, Frankel LA, Christensen KD, Islam R, Robinson JO, et al. Psychosocial effect of newborn genomic sequencing on families in the BabySeq project: a randomized clinical trial. JAMA Pediatr. 2021;175:1132. https://doi.org/10.1001/jamapediatrics.2021.2829.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Soft 2015;67. https://doi.org/10.18637/jss.v067.i01.

  39. Bolger N, Laurenceau J-P. Intensive longitudinal methods: an introduction to diary and experience sampling research. Guilford Press 2013;xv:256.

  40. Hartig F. DHARMa: residual diagnostics for hierarchical (Multi-Level / Mixed) Regression Models. R package version 0.4.7. 2024. https://CRAN.R-project.org/package=DHARMa.

  41. Pustejovsky J. clubSandwich: cluster-robust (Sandwich) variance estimators with small-sample corrections. R package version 0.5.11. 2024; https://CRAN.R-project.org/package=clubSandwich.

  42. Lenth RV, Piaskowski J. emmeans: estimated marginal means, aka least-squares means. R package version 1.11.0. 2025; https://CRAN.R-project.org/package=emmeans.

  43. Doll ES, Alex K, Mayer CJ, Brennenstuhl H, Mütze U, Smith H, et al. A population representative survey on attitudes towards genomic newborn screening in Germany. Genetics in Medicine Open. 2026;104371. https://doi.org/10.1016/j.gimo.2026.104371

  44. Downie L, Halliday J, Lewis S, Amor DJ. Principles of genomic newborn screening programs: a systematic review. JAMA Netw Open. 2021;4:e2114336 https://doi.org/10.1001/jamanetworkopen.2021.14336.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lautenbach DM, Christensen KD, Sparks JA, Green RC. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu Rev Genomics Hum Genet. 2013;14:491–513. https://doi.org/10.1146/annurev-genom-092010-110722.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Spiegelhalter D, Pearson M, Short I. Visualizing uncertainty about the future. Science. 2011;333:1393–400. https://doi.org/10.1126/science.1191181.

    Article  PubMed  Google Scholar 

  47. Viberg Johansson J, Segerdahl P, Ugander UH, Hansson MG, Langenskiöld S. Making sense of genetic risk: a qualitative focus-group study of healthy participants in genomic research. Patient Educ Counseling. 2018;101:422–7. https://doi.org/10.1016/j.pec.2017.09.009.

    Article  Google Scholar 

  48. Cameron LD, Sherman KA, Marteau TM, Brown PM. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol. 2009;28:307–16. https://doi.org/10.1037/a0013947.

    Article  PubMed  Google Scholar 

  49. Wolff K, Nordin K, Brun W, Berglund G, Kvale G. Affective and cognitive attitudes, uncertainty avoidance and intention to obtain genetic testing: an extension of the theory of planned behaviour. Psychol Health. 2011;26:1143–55. https://doi.org/10.1080/08870441003763253.

    Article  PubMed  Google Scholar 

  50. O’Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, et al. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. Am J Med Genet Part C: Semin Med Genet. 2006;142C:251–9. https://doi.org/10.1002/ajmg.c.30104.

    Article  PubMed  Google Scholar 

  51. Janssen E, van Osch L, Lechner L, Candel M, de Vries H. Thinking versus feeling: Differentiating between cognitive and affective components of perceived cancer risk. Psychol Health. 2012;27:767–83. https://doi.org/10.1080/08870446.2011.580846.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study was conducted within the project “NEW_LIVES” (https://www.klinikum.uni-heidelberg.de/en/new-lives-genomic-newborn-screening-programs). We thank the members of the NEW_LIVES project team for the valuable discussions and feedback during the study conduct.

Funding

The study was conducted within the ELSI funding line of the German Federal Ministry of Education and Research (BMBF), since 2025, Federal Ministry of Research, Technology and Space (BMFTR) grant number 01GP2201A and 01GP2201B to EW, RM-T, BD, CS, and SK. The authors confirm independence from the sponsor; the content of the article has not been influenced by the sponsor. Open Access funding enabled and organized by Projekt DEAL.

Author information

Author notes

  1. These authors contributed equally: Hadley Stevens Smith, Beate Ditzen.

Authors and Affiliations

  1. Heidelberg University, Heidelberg, Germany

    Elena Sophia Doll, Julia Mahal & Beate Ditzen

  2. Institute for Medical Psychology, Heidelberg University Hospital, Heidelberg, Germany

    Elena Sophia Doll, Julia Mahal & Beate Ditzen

  3. Heidelberg University, Faculty of Medicine, Institute for Medical and Data Ethics, Heidelberg, Germany

    Karla Alex & Eva C. Winkler

  4. Laboratory for Clinical Neuropsychology, Department of Psychology, Heidelberg University, Heidelberg, Germany

    Carlotta Julia Mayer

  5. Division of Child Neurology and Metabolic Medicine, Medical Faculty, Center for Child and Adolescent Medicine, Heidelberg University, Heidelberg, Germany

    Ulrike Mütze & Stefan Kölker

  6. Institute of Human Genetics, Heidelberg University, Heidelberg, Germany

    Heiko Brennenstuhl & Christian P. Schaaf

  7. Faculty of Law, Public Law, Law of Economic Regulation and Media, University of Mannheim, Mannheim, Germany

    Ralf Müller-Terpitz

  8. German Center for Mental Health (DZPG), Partner site Heidelberg/Mannheim/Ulm, Heidelberg, Germany

    Christian P. Schaaf & Beate Ditzen

  9. PRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA

    Hadley Stevens Smith

  10. Clinical Biopsychology and Psychotherapy, Department of Psychology, University of Zurich, Zurich, Switzerland

    Beate Ditzen

Authors

  1. Elena Sophia Doll
  2. Julia Mahal
  3. Karla Alex
  4. Carlotta Julia Mayer
  5. Ulrike Mütze
  6. Heiko Brennenstuhl
  7. Ralf Müller-Terpitz
  8. Stefan Kölker
  9. Christian P. Schaaf
  10. Eva C. Winkler
  11. Hadley Stevens Smith
  12. Beate Ditzen

Contributions

Conceptualization: BD, ESD and JM; Data curation: ESD; Formal analysis: ESD; Funding acquisition: BD, CPS, ECW, RMT and SK; Investigation: ESD and JM; Methodology: ESD, CJM and HSS; Project administration: BD; Resources: BD; Software—Supervision: BD and HSS; Validation: ESD and JM; Visualization: ESD; Writing-original draft: ESD; Writing-review and editing: BD, CJM, CPS, ESD, ECW, HB, HSS, JM, KA, SK, UM, and RMT.

Corresponding authors

Correspondence to Elena Sophia Doll or Beate Ditzen.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

The study was approved by the ethics committee of Heidelberg Medical Faculty (S-215/2024). Informed consent was obtained from all participants.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doll, E.S., Mahal, J., Alex, K. et al. Parental reactions to and preferences for genomic newborn screening in Germany: findings from a scenario-based survey experiment. Eur J Hum Genet (2026). https://doi.org/10.1038/s41431-026-02253-0

Download citation

  • Received: 30 January 2026

  • Revised: 26 July 2026

  • Accepted: 16 September 2026

  • Published: 08 October 2026

  • Version of record: 08 October 2026

  • DOI: https://doi.org/10.1038/s41431-026-02253-0

来源:Nature 健康护理主题 · nature.com